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18F-Choline Images Murine Atherosclerotic Plaques Ex Vivo
Christian M. Matter, Matthias T. Wyss, Patricia Meier, Nicolas Spa¨th, Tobias von Lukowicz,
Christine Lohmann, Bruno Weber, Ana Ramirez de Molina, Juan Carlos Lacal, Simon M. Ametamey,
Gustav K. von Schulthess, Thomas F. Lu¨scher, Philipp A. Kaufmann, Alfred Buck
Objective—Current imaging modalities of atherosclerosis mainly visualize plaque morphology. Valuable insight into
plaque biology was achieved by visualizing enhanced metabolism in plaque-derived macrophages using 18F-
fluorodeoxyglucose (18F-FDG). Similarly, enhanced uptake of 18F-fluorocholine (18F-FCH) was associated with
macrophages surrounding an abscess. As macrophages are important determinants of plaque vulnerability, we tested
18F-FCH for plaque imaging.
Methods and Results—We injected 18F-FCH (n5) or 18F-FDG (n5) intravenously into atherosclerotic apolipoprotein
E-deficient mice. En face measurements of aortae isolated 20 minutes after 18F-FCH injections demonstrated an
excellent correlation between fat stainings and autoradiographies (r0.842, P0.0001), achieving a sensitivity of 84%
to detect plaques by 18F-FCH. In contrast, radiotracer uptake 20 minutes after 18F-FDG injections correlated less with
en face fat stainings (r0.261, P0.05), reaching a sensitivity of 64%. Histological analyses of cross-sections 20
minutes after coinjections of 18F-FCH and 14C-FDG (n3) showed that 18F-FCH uptake correlated better with fat
staining (r0.740, P0.0001) and macrophage-positive areas (r0.740, P0.0001) than 14C-FDG (fat: r0.236,
P0.29 and CD68 staining: r0.352, P0.11), respectively.
Conclusions—18F-FCH identifies murine plaques better than 18F-FDG using ex vivo imaging. Enhanced 18F-FCH uptake
into macrophages may render this tracer a promising candidate for imaging plaques in patients. (Arterioscler Thromb
Vasc Biol. 2006;26:584-589.)
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Current clinical tools to image atherosclerotic plaquessuch as intravascular ultrasound, computed tomography
(CT), magnetic resonance imaging (MRI), or optical coher-
ence tomography (OCT) provide morphological images of
the vessel wall at remarkable spatial resolution.1–4 However,
these imaging modalities are unable to characterize details of
plaque biology. More insight into plaque biology would be
desirable to determine a better risk assessment of the vulner-
able plaque.5 The vulnerable plaque, because of its risk of
rupturing, is considered the culprit lesion causing acute
arterial obstruction, which may result in myocardial infarc-
tion or stroke.
Therefore, plaque imaging using molecular targets has
gained increased attention.6 For example, positron emission
tomography (PET) provides attractive opportunities to visu-
alize plaque biology.7 Specifically, 18F-fluorodeoxyglucose
(18F-FDG)—a widely used PET tracer—has been clinically
used to image enhanced metabolism of cellular components
of the plaque including macrophages.8 Other studies have
confirmed the relevance of 18F-FDG for plaque imaging in
Watanabe rabbits9 and in patients with calcifications of the
arterial wall10 or active atherosclerosis.11 These studies are of
interest as macrophages play a crucial role in atherogenesis
and, particularly, in plaque rupture.12,13
18F-labeled fluorocholine (18F-FCH) has been introduced as a
tracer for imaging brain and prostate cancer.14,15 Choline is taken
up into cells by specific transport mechanisms, phosphorylated
by choline kinase, metabolized to phosphatidylcholine, and
eventually incorporated into the cell membrane.16–18 Increased
choline uptake has been shown in tumor cells19 and activated
macrophages.17 Based on this concept, we have recently dem-
onstrated an enhanced 18F-FCH uptake that correlated with
macrophage accumulation as part of an inflammatory reaction
after soft tissue infection20 or acute cerebral radiation injury.21
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Therefore, we compared the ability of 18F-FCH and 18F-
FDG to image murine atherosclerotic plaques ex vivo and
validated these results against fat staining.
Materials and Methods
For more details, please see http://atvb.ahajournals.org.
Animals
Male atherosclerotic apolipoprotein E knockout (ApoE/, C57Bl/6J)
mice22 were fed a high-cholesterol diet (1.25% total cholesterol;
RD12108; Research Diets) for 2 months starting at the age of 8
weeks. Animals were kept without food for 4 hours before injections
of the radiotracers until sacrifice. A subset of wild-type C57Bl/6J
mice without atherosclerosis received a normal chow diet. All animal
experiments were performed in accordance with our institutional
guidelines and approved by the local animal committee.
Radionuclides
Ex vivo plaque imaging was performed after injections of 18F-FCH
(45.8 to 60.5 MBq; n5), 18F-FDG (36.7 to 46.4 MBq; n5), or
coinjections of 18F-FCH and 14C-FDG (185kBq; n3) in 300 L
normal saline into the animals’ tail veins.
Harvesting and Tissue Processing
For determining the uptake of 18F-FCH, 18F-FDG, or 14C-FDG within
plaques, ApoE/ mice were euthanized 20 minutes after injection of
the radiotracer(s); additional animals were euthanized 3 hours after
18F-FDG injections. For en face analyses, distal aortae were opened
longitudinally. For microscopic examinations, 3 samples of the
proximal aorta were embedded in OCT compound (Tissue-Tek,
Sakura, the Netherlands) and frozen in isopentane. Serial cross-
sections of 10 m thickness were immediately cut and thaw-
mounted on glass slides. Autoradiography and fat stainings were
performed on the same samples (n12 from each animal). For
biochemical analyses, aortae from ApoE/ (n3) and wild-type
mice (n3) were shock-frozen in liquid nitrogen (LN2) and stored at
80°C.
Choline Kinase Activity and Expression
For more details, please see http://atvb.ahajournals.org.
Plaque Imaging
Morphology
Plaque areas were assessed via fat staining using Oil-red O. Macro-
phages were identified on adjacent cross-sections using a rat anti-
mouse CD68 monoclonal antibody (Serotec, Clone FA-II, 1:400).
Autoradiography
For en face macroautoradiography, aortae were longitudinally
opened and exposed on a phosphor imaging screen with 14C
standards (for 4 hours with 18F-labeling; for 10d using 14C-labeling).
Furthermore, aortic cross-sections of 10 m thickness were exposed
with 14C standards for microautoradiography. The data were scanned
(Fuji BAS 1800 II; pixel size, 50 m) and converted to kBq/cc.
Signal Quantification
The lesion-to-nonlesion ratio in autoradiographies of longitudinally
opened aortae was determined using linear integration of signal
intensity (NIH Image J 1.33 software) over corresponding aortic
areas taking the mean of 5 measurements from each animal. The
corresponding ratio in 3 cross-sections of the proximal aorta was
determined after injections of 18F-FCH or 18F-FDG by relating the
signal intensity of a region of interest within the plaque to a region
without lesion. In addition, the standardized uptake value (SUV) was
obtained for each animal by dividing the target tissue radioactivity
uptake (kBq/cc) within a region of interest by the injected activity
per gram of body weight. Comparisons between en face fat stainings
and corresponding autoradiographies were determined by converting
the autoradiographies into color-coded images, tracing all positive
areas (Analysis Five Docu, SoftImaging System) and correlating the
percent positive of the total vessel areas using the Spearman rank
correlation test (GraphPad Prism V4). Analogous comparisons were
performed on 3 cross-sections of each animal in the proximal aorta
after coinjections of 18F-FCH and 14C-FDG (n3) for autoradiogra-
phies, fat, and CD68 stainings.
Mouse PET
For more detail, please see http://atvb.ahajournals.org.
Statistics
An unpaired t test was used to compare results between different
groups. Values are given as meanSD; P0.05 was considered
statistically significant.
Results
18F-FCH Macroscopically Visualizes Murine
Atherosclerotic Plaques
En face analysis of atherosclerotic plaques revealed a strong
and selective uptake of 18F-FCH (Figure 1A). The mean
signal-to-noise ratio of these macroautoradiographies relating
radioactivity uptake in plaque-bearing to plaque-free vessel
wall was 4.92.0 to 1 (n5). Comparisons of the corre-
sponding en face autoradiographic signals and fat stainings in
single plaques demonstrated a highly significant correlation
(r0.842, P0.0001) and a sensitivity of 84% to detect
fat-stained areas by autoradiography. Because 18F-FCH up-
take in rodents and men reaches a plateau 20 minutes after
radiotracer injection,14,15,20,21,23 we did not study further time
intervals for plaque imaging using 18F-FCH.
18F-FDG Visualizes Murine Plaques Less
Specifically Than 18F-FCH
In light of previous reports with 18F-FDG to image plaque
biology in rabbits9 and patients,8,10,11 we validated the ability
of 18F-FDG to image murine atherosclerotic plaques applying
the same experimental protocol as described for 18F-FCH; 20
minutes after injection, 18F-FDG uptake on autoradiography
correlated poorly with the fat staining of plaques (Figure 1B,
top). The mean signal-to-noise ratio of radioactivity uptake in
plaque-bearing versus plaque-free vessel wall was 6.05.1 to
1 (n5). The sensitivity of the autoradiography after 18F-FDG
injection was only 64% to detect the fat-stained areas.
Comparisons of the corresponding en face autoradiographic
signals and fat stainings (Figure 1B) documented a lower
correlation (r0.261, P0.05) than for 18F-FCH.
Given the clinical report describing an interval of 3 hours
as the optimal time course for 18F-FDG imaging using
PET-CT,8 we investigated whether harvesting aortae 3 hours
after intravenous 18F-FDG injections would affect plaque
imaging ex vivo. Comparisons between en face autoradiog-
raphies and fat stainings 3 hour post radiotracer injections
(Figure 1B, bottom; n3) revealed a slightly better correla-
tion (r0.476, P0.001; Table) than after 20 minutes.
However, the mean signal-to-noise ratio of radioactivity
uptake in plaque-bearing versus plaque-free vessel wall
decreased to 2.60.9 to 1 (n3). In addition, because of a
high rate of 76% false-negative autoradiographic signals, the
sensitivity of the autoradiography 3 hours after 18F-FDG
injection was only 57% to detect the fat-stained areas.
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18F-FCH Uptake Colocalizes With Plaques
Using Microautoradiography
Analyses of cross-sections from the proximal aorta showed
that 18F-FCH uptake correlated well with plaques (Figure
2A), whereas 18F-FDG uptake showed a lower sensitivity to
identify atherosclerotic plaques (Figure 2B). The maximum
of the SUV in the plaque was 1.81.0 for 18F-FCH and
2.40.5 for 18F-FDG (n5; not significant [NS]). In addition,
the signal-to-noise ratio (plaque-bearing vessel portion to
plaque-free vessel wall) was 3.50.9 to 1 for 18F-FCH and
2.90.5 to 1 for 18F-FDG (NS).
18F-FCH Uptake Colocalizes With
Plaque Macrophages
Autoradiographic analyses of aortic cross-sections after in-
travenous coinjections of 18F-FCH and 14C-FDG into the same
ApoE/ mice showed similar radionuclide uptake in plaque-
bearing vessel areas (Figure 3A, top; Table). Under these
conditions, the signal-to-noise ratio (lesion to nonlesion)
calculated from the SUV was 2.50.4 to 1 for 18F-FCH and
2.41.1 to 1 for 14C-FDG (n3; NS).
Figure 1. Macroscopically, 18F-fluorocholine (18F-FCH) better
visualizes murine plaques than 18F-fluorodeoxyglucose (18F-
FDG). A, Macroautoradiographies (left) and fat stainings using
Oil-red O (right) of longitudinally opened aortae 20 minutes after
injection of 18F-FCH in atherosclerotic apolipoprotein E knockout
(ApoE/) mice (3 samples of n5). Comparisons of corre-
sponding images obtained after autoradiography and fat stain-
ing by tracing each positive area (given as % of total vessel
area) demonstrate a highly significant correlation (r0.842,
P0.0001). Each white circle (n89) refers to a single autora-
diographic signal and its corresponding plaque staining. The
insert illustrates the same findings on a log scale. B, Macroauto-
radiographies (left) and fat stainings (right) of aortae 20 minutes
(top, 3 samples of n5) and 3 hours (bottom, n3) after injec-
tion of 18F-FDG in atherosclerotic apolipoprotein E knockout
(ApoE/) mice. Comparisons of corresponding images obtained
after autoradiography and fat staining by tracing each positive
area using linear regression document a poor correlation for 18F-
FDG after 20 minutes (r0.261, P0.05) and after 3 hours
(r0.476, P0.001). Each white circle (n73 for 20 minutes,
n58 for 3 hours) refers to a single autoradiographic signal and
its corresponding plaque staining.
Validation of 18F-FCH or 14C-FDG for Imaging Murine Plaques or
Macrophages Ex Vivo in Cross-sections
Radiotracer 18F-FCH 14C-FDG
n (mice) 3 3
n (total plaques analyzed) 22 22
Correlation r (Spearman; tracer vs fat staining) 0.740 0.236
P value (Spearman; tracer vs fat staining) 0.0001 0.29
Correlation r (Spearman; tracer vs CD68 staining) 0.740 0.352
P value (Spearman; tracer vs CD68 staining) 0.0001 0.11
SUV 2.50.4 to 1 2.41.1 to 1
False negative autoradiography for fat staining, % 5 18
Sensitivity of tracer for fat staining, % 95 82
Sensitivity of tracer for CD68 staining, % 96 85
Comparisons of single autoradiographic signals (20 minutes after coinjec-
tions of 18F-FCH and 14C-FDG), fat, and CD68 stainings in 3 cross-sections of
atherosclerotic aortae; meanSD.
Figure 2. 18F-FCH visualizes atherosclerotic plaques at the
microscopic level. Color-coded microautoradiographies (top)
and Oil-red O/hematoxyline stainings (bottom) of aortic cross-
sections 20 minutes after injection of 18F-FCH (A) (45.8 to 60.5
MBq) or 18F-FDG (B) (36.7 to 46.4 MBq) in apolipoprotein E
knockout (ApoE/) mice (n5). Autoradiographic signals
derived from 18F-FCH or 18F-FDG uptake colocalize to a similar
degree with fat staining. The color calibration (right) indicates
the SUV for 18F-FCH or 18F-FDG, respectively; bar500 m.
586 Arterioscler Thromb Vasc Biol. March 2006
 by on May 28, 2010 atvb.ahajournals.orgDownloaded from 
Staining of adjacent cross-sections for macrophages using
an anti-CD68 antibody (Figure 3A, bottom) revealed that
18F-FCH uptake correlated better with fat staining (r0.740,
P0.0001) and CD68 positive areas (r0.740, P0.0001;
Figure 3B, top; Table) than 14C-FDG (fat: 0.236, P0.29 and
CD68 staining: 0.352, P0.11; Figure 3B, bottom),
respectively.
18F-FCH Mouse PET
Mouse PET scans obtained 10 to 30 minutes after 18F-FCH
injections could not detect a specific tracer uptake in athero-
sclerotic aortae of ApoE/ mice but showed an increased
unspecific 18F-FCH uptake in metabolically active tissues
such as heart and liver. Subsequent en face analyses of these
aortae revealed a good colocalization of autoradiographies
and fat stainings.
Choline Kinase Expression and Activity Are
Unchanged in Atherosclerotic Versus
Normal Aortae
As an increased choline uptake in tumor cells has been related
to an upregulation of choline kinase and/or choline transport
mechanisms,17,19 we compared expression and activity of
choline kinase in atherosclerotic versus normal aortae iso-
lated from ApoE/ or wild-type mice, respectively. Both
choline kinase expression and activity were similar. No
methods are currently available for investigating choline
transport in vivo.
Discussion
It is now well-recognized that plaque formation is a complex,
noncontinuous process and that plaque rupture is not just a
matter of size (ie, morphology), but mainly the consequence
of plaque vulnerability (ie, biology). Thus, imaging of vul-
nerable plaques constitutes a great need in cardiovascular
medicine.5
In this study, we describe for the first time to our
knowledge 18F-FCH as a promising agent for imaging bio-
logical properties of murine atherosclerotic plaques using ex
vivo macroautoradiography and microautoradiography. At
the cellular level, uptake of 18F-FCH correlated significantly
with plaque macrophages. These findings extend our previous
studies in which we described 18F-FCH for noninvasive
imaging of a soft tissue infection in a rat model.20
Activated macrophages have been shown to play a key role
in promoting atherogenesis. For example, by infiltrating the
intimal layer, they replicate, become foam cells, and express
and secrete hazardous inflammatory molecules within the
arterial wall. Particularly, their formation of enzymes such as
matrix metalloproteinases (MMPs) leads to thinning of the
fibrous cap, thereby increasing the vulnerability of
plaques.12,13
Enhanced 18F-FDG uptake was recently reported in plaques
of atherosclerotic rabbits9 and humans.8,10,11 Furthermore,
increased 18F-FDG uptake in unstable plaques colocalized
with plaque macrophages,8 suggesting increased metabolic
activity. Thus, these authors proposed enhanced 18F-FDG
uptake in human plaques as a typical sign of plaque vulner-
ability. These reports and our previous findings inspired us to
perform a side-by-side comparison of en face preparations 20
minutes after 18F-FCH or 18F-FDG injections complemented
by cross-sections after simultaneous injections of 18F-FCH
and 14C-FDG into ApoE/ mice. As image acquisition 3
Figure 3. 18F-FCH correlates with plaque macrophages. A, Aortic cross-sections after coinjections of 18F-FCH and 14C-FDG into the
same ApoE/ mice were exposed over 4 hours (18F-FCH uptake), then re-exposed for 10 days (14C-FDG uptake) followed by fat stain-
ing. Anti-CD68 stainings identified macrophages in adjacent sections. Representative photomicrographs of cross-sections from 3 differ-
ent animals are shown. The color calibration (right) indicates the SUV for 18F-FCH or 14C-FDG, respectively; bar500 m. B, Uptake of
18F-FCH in cross-sections (upper panel) correlates well with fat stainings (r0.740, P0.0001) or CD68 stainings (r0.740, P0.0001).
14C-FDG uptake (lower panel) correlated less with fat (0.236, P0.29) or CD68 staining (0.352, P0.11). Each white circle (n22) refers
to a single autoradiographic signal and its corresponding fat or CD68 staining.
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hours after 18F-FDG injection was identified as the optimal
time point for visualizing human vulnerable plaques via
PET-CT,8 we also investigated ex vivo imaging of murine
plaques 3 hours after 18F-FDG administration. Our macro-
scopic en face measurements demonstrated that uptake of
FCH visualizes murine plaques more specifically than FDG
20 minutes or 3 hours after radiotracer injection. In particular,
the sensitivity for detecting plaques ex vivo was best for
18F-FCH, lower for 18F-FDG at 20 minutes, and lowest 3
hours after 18F-FDG at injection. In addition, our histological
analyses revealed that 18F-FCH uptake correlated signifi-
cantly with fat and macrophage stainings better than the
corresponding correlations of 14C-FDG uptake. These macro-
autoradiographic and microautoradiographic findings suggest
that FCH may even be better than FDG for visualizing murine
plaques ex vivo and render 18F-FCH a promising candidate
for noninvasive imaging of plaque metabolism.
To be applicable for noninvasive plaque imaging, the
radiolabeled particles not only have to accumulate within the
target tissue, they also have to be cleared quickly from the
circulating blood to provide a sufficient signal-to-noise ratio
for scintigraphy or PET imaging. For this purpose, 18F-FCH
appears a suitable and promising tool given its rapid blood
clearance rate.23 However, our 18F-FCH PET scans of
ApoE/ mice did not allow us to detect a plaque-specific
signal. We think that this was caused by: (1) the difficulty to
relate the PET signal to a specific anatomic structure; (2) the
limited spatial resolution of small animal PET (1 mm) to
detect even smaller murine plaques (200 to 500 m); (3)
the unspecific uptake of 18F-FCH in metabolically active
tissues such as liver and heart; and (4) the moderate SUV of
18F-FCH as suggested by our experiments. However, we
speculate that human plaque imaging using 18F-FCH is
feasible because of: (1) the opportunity to create hybrid
images by combining high spatial resolution morphological
imaging using CT or MRI with PET; (2) the considerably
bigger size of human compared with murine plaques; (3) the
similar SUV for 18F-FDG and 18F-FCH; and (4) the feasibility
of human plaque imaging using 18F-FDG.8
Radiolabeled choline is known as a proliferation marker
and has been used for imaging brain and prostate cancer.14,15
The increased choline uptake in highly proliferative cells
such as tumor cells has been related to an upregulation of
choline kinase as well as an increased activity of choline-
specific transporters.19,24 We show similar levels of choline
kinase expression and activity in normal and atherosclerotic
murine aortae. Thus, enhanced 18F-FCH uptake in activated
murine plaque macrophages is not caused by changes in
choline kinase, but rather by increased choline transport. The
rapid uptake (within 30 minutes) of 18F-FCH into prostate
cancer14,15 or inflammatory tissues20 supports this notion.
Interestingly, choline and FCH are trapped in the cells,
whereas the nonmetabolizable choline analogue 18F-
deshydroxy-FCH, which also uses the specific transport
system, is weakly incorporated in the cells.24 Thus, accumu-
lation of FCH 20 minutes after injection in our study suggests
a specific uptake, because nonspecific transport would not
lead to intracellular radiotracer accumulation.
Other radionuclide-based approaches for imaging plaque
biology have been reported using radiotracers such as
technetium (99mTc)-linked, Indium (111In)-linked, or iodine
(125I, 131I)-linked compounds.7 Many of the previous studies
used macrophage labeling to characterize one important
aspect of plaque vulnerability.25 For example, 99mTc-
labeled Annexin V visualized apoptotic macrophages in
plaques of atherosclerotic rabbits26 and in a small number
of patients.27 Similarly, uptake of 125I-linked monocyte
chemoattractant protein 1 (MCP-1) revealed an excellent
correlation with macrophages in aortic plaques of athero-
sclerotic rabbits.28 Scha¨fers et al recently reported on
scintigraphic imaging of matrix metalloproteinase (MMP)
activity in ligation-induced and cholesterol-induced ca-
rotid lesions of ApoE/ mice using a 123l-labeled MMP
inhibitor.29 Similar to our results, the radiotracer signal in
these lesions colocalized with activated macrophages.
However, the impact of these findings with regard to
imaging of murine atherosclerotic plaques has to be
interpreted with caution as the type of lesions after
complete carotid ligation30 is different from atherosclerotic
plaques in terms of pathophysiology, cellular contents, and
size.
Overall, given its limited spatial resolution, scintigraphic
imaging using single-photon emission CT (SPECT) may
severely limit the detection of small plaques. When compared
with SPECT, PET is superior in terms of image resolution
(4 mm versus 10 mm) and sensitivity. Although even PET-
based devices do not have the spatial resolution to provide
detailed tissue characterization, the lesions can be detected if
there is a sufficiently high target-to-background ratio. Fur-
thermore, the limited spatial resolution can be addressed by
hybrid imaging, which combines radionuclide-based visual-
ization of plaque biology with imaging modalities that pro-
vide better anatomic detail such as multislice CT2 or MRI.31
For example, PET-CT has been applied successfully at our
institution for staging lung cancer32 or assessing myocardial
perfusion.33 As mentioned, PET-CT has also been used for
imaging plaque metabolism using 18F-FDG.8 Unfortunately,
FDG and FCH are taken up into other metabolically active
tissues such as myocardium or liver, a problem that currently
excludes its use for imaging coronary atherosclerosis. Finally,
the advent of catheter-based devices may provide an attrac-
tive tool for invasive detection of plaques.34 The proximity of
the -probe close to the target is likely to improve the
detection of plaque-associated radioactive signals. Combin-
ing this approach with high-resolution morphological imag-
ing such as OCT4 would offer an attractive technique for
detailed imaging of plaque biology.
In conclusion, our findings characterize 18F-FCH as a novel
agent for imaging relevant aspects of plaque biology. Its
colocalization with plaque macrophages may render it an
additional marker of vascular inflammation suggesting vul-
nerability of an atherosclerotic plaque. Its favorable pharma-
cokinetics with rapid blood clearance as well as the opportu-
nity to visualize 18F-FCH noninvasively by PET-CT may
render this approach an attractive tool for risk stratification of
atherosclerotic lesions in patients.
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Materials and Methods 
Animals 
Male atherosclerotic apolipoprotein E knockout (ApoE-/-, C57Bl/6J) mice 1 were obtained from 
Jackson Laboratories (Bar Harbor, ME, USA) and bred at our institution. These animals were fed a high-
cholesterol diet (1.25% total cholesterol, RD12108 from Research Diets, USA) for 2 months starting at the 
age of 8 weeks. Animals were kept without food for 4 hours prior to injections of the radiotracers until 
sacrifice. A subset of wild-type C57Bl/6J mice without atherosclerosis received a normal chow diet. They 
were used as control animals for biochemical analyses. All animal experiments were performed in 
accordance with our institutional guidelines and approved by the local animal committee. 
 
Radionuclides 
Ex vivo plaque imaging was performed following intravenous (i.v.) injections of 18F-FCH (45.8–
60.5 MBq; n=5), 18F-FDG (36.7–46.4 MBq; n=5) or coinjections of 18F-FCH and 14C-FDG (185kBq; n=3) in 
300μl normal saline into the animal’s tail vein. 
 
Harvesting and tissue processing 
For determining the uptake of 18F-FCH, 18F-FDG or 14C-FDG within plaques, ApoE-/- mice were 
sacrificed 20 minutes after injection of the radiotracer(s); additional animals were euthanized 3 hours after 
18F-FDG injections. After puncturing the left ventricle and cutting the right atrium, vessels were rinsed 
briefly with normal saline and the aorta excised after removing adventitial tissue. For en face analyses, 
distal aortae (from the left subclavian artery to the iliac bifurcation) were opened longitudinally. For 
microscopic examinations, 3 samples of the proximal aorta (ascending, mid and distal arch) were 
embedded in OCT compound (Tissue-Tek, Sakura, The Netherlands) and frozen in isopentane. Serial 
cross sections of 10μm thickness (at 100μm intervals) were immediately cut and thaw-mounted on glass 
slides. Autoradiography and fat stainings were performed on the same samples (n=12 from each animal). 
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Adjacent cross sections were saved for immunohistochemistry. For biochemical analyses, aortae from 
ApoE-/- (n=3) and wild-type mice (n=3) were shock-frozen in liquid nitrogen and stored at -80°C. 
Choline kinase activity and expression 
For tissue extracts, samples were homogenized in buffer containing 1.5mM MgCl2, 0.2mM EDTA, 
0.3M NaCl 25mM HEPES pH 7.5, 20mM β-glycerophosphate and 0.1% TRITON X-100. Choline kinase 
(CHK) assays were performed from homogenized tissues in buffer containing 100mM Tris-HCl pH 8.0, 
100mM MgCl2 and 10mM ATP. Physiological choline concentration (200μM) was used as substrate in the 
presence of methyl[14C]-choline chloride (50-60Ci/mmol, Amersham International). Reactions were 
performed at 37°C for 30 minutes and stopped with ice cold 16% trichloracetic acid. Hydrophylic 
derivatives of choline (i.e. phosphorylcholine) were resolved by thin layer chromatography plates (60 A 
silica gel, Whatman, Clifton, NJ) using as liquid phase 0.9% NaCl: methanol: ammonium hydroxide 
(50:70:5; V:V:V). Radioactivity corresponding to P-Choline was quantified by an electronic radiography 
system (Instantimager; Packard, Meriden, CT). Equal amounts of protein (30μg) from the different tissue 
lysates were used for Western blot analysis using a monoclonal antibody raised against human choline 
kinase α that also recognizes mouse choline kinase (Gallego-Ortega et al., unpublished data, 2005) and 
then developed by ECL as described by the manufactures (Amersham). α-tubulin (T9026, Sigma) was 
used as a loading control. 
 
Plaque imaging 
Plaque imaging was performed ex vivo in 3 dimensions by combining macroscopic measurements 
of en face preparations of the thoraco-abdominal aorta with microscopic analyses of cross-sections of the 
proximal aorta. 
Morphology: Plaque areas were assessed via fat staining using Oil-red O. Macrophages were 
identified using a rat anti-mouse CD68 monoclonal antibody (Serotec, Clone FA-II, 1:400), a goat anti-rat 
secondary antibody (IgG, Caltag R40000, 1:150) followed by an alkaline phosphatase-conjugated donkey 
anti-goat antibody (IgG, Jackson 705-055-147, 1:80). Sections were counterstained with hematoxyline. 
C. M. Matter et al.: 18F-choline for plaque imaging – supplemental online material 3 
 
Autoradiography: Two different methods were employed in order to assess tracer uptake. For en 
face autoradiography, aortae were longitudinally opened and exposed on a phosphor imaging screen with 
14C standards (for 4 hours with 18F-labeling – for 10d using 14C labeling). Furthermore, aortic cross-
sections of 10μm thickness were exposed with 14C standards for microautoradiography. The data were 
scanned (Fuji BAS 1800 ΙΙ, pixel size: 50μm) and converted to kBq/cc. For this conversion, the 14C 
standards were previously recalibrated using a 4-hour exposure of 10μm slices of a brain homogenate 
containing a defined amount of 18F activity. 
Signal quantifications: The lesion-to-nonlesion ratio in autoradiographies of longitudinally opened 
aortae was determined using linear integration of signal intensity (NIH Image J 1.33 software) over 
corresponding aortic areas taking the mean of 5 measurements from each animal. The corresponding 
ratio in 3 cross-sections of the proximal aorta was determined after injections of 18F-FCH or 18F-FDG by 
relating the signal intensity of an area of interest within the plaque to an area without lesion. In addition, 
the standardized uptake value (SUV) was obtained for each animal by dividing the target tissue 
radioactivity uptake (kBq/cc) within a region of interest by the injected activity per gram of body weight. 
Comparisons between en face fat stainings and corresponding autoradiographies were determined by 
converting the autoradiographies into color-coded images using the software PMOD 2, tracing all positive 
areas (Analysis Five Docu, Software from SoftImaging System) and correlating the % positive out of the 
total vessel areas using the Spearman rank correlation test (GraphPad Prism V4). Similar comparisons 
were performed from 3 aortic cross sections after coinjections of 18F-FCH and 14C-FDG (n=3) for 
autoradiographies, fat and CD68 stainings. For all above mentioned calculations, multiple plaques on the 
aorta of one animal were considered independent samples; 0 values were inserted with absence of a 
corresponding value of either plaques or autoradiographies. 
Mouse Positron Emission Tomography (PET): PET experiments were performed on the 16-
module variant of the NanoPET™ tomograph (Oxford Positron Systems; Weston-on-the-Green, UK) as 
described 3. PET scans were obtained 10 to 30 min after intravenous 18F-FCH (18.62–19.63) injections in 
atherosclerotic ApoE-/- mice (n=3). Harvestings of aortae for en face analyses were performed 40 minutes 
after the radiotracer injections. 
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Statistics 
An unpaired t-test was used to compare results between different groups. Values are given as 
mean±SD; P<0.05 was considered statistically significant. 
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Figures and Table 
 
 
Figure I 
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Figure I: PET scans and ex vivo autoradiographies after 18F-choline injections. 
(A) PET scans obtained 10 to 30 min after intravenous 18F-FCH (18.62–19.63 MBq, n=3) injections did not 
allow to detect a specific tracer uptake in plaques of atherosclerotic aortae of ApoE-/- mice, but showed an 
increased 18F-FCH uptake in metabolically active tissues such as heart and liver. Left panel: above left: 
frontal plane, above right: sagittal plane; bottom left: horizontal plane; right panel: cross sections from 
cranial (top) to caudal (bottom). (B) Subsequent en face analyses of atherosclerotic aortae 40 minutes 
after 18F-FCH injection revealed a good colocalization of autoradiographies (right) and fat stainings (left). 
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Figure II 
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Figure II. Similar choline kinase expression and activity in atherosclerotic and normal murine 
aortae. 
Analysis of aortic lysates from atherosclerotic ApoE-/- (n=3) or normal wild-type (WT, n=3) mice reveal 
similar choline kinase (ChoK) expression by Western blotting (A) and subsequent densitometric 
quantifications (NS, B). In parallel, choline kinase activity measured by the amount of phospho-choline 
(PCho; C) was not different in lysates obtained from atherosclerotic (n=3) or normal (n=3) aortae (n=3, 
NS). 
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Table I. Validation of 18F-FCH or 18F FDG for imaging murine plaques ex vivo en face. 
 
Radiotracer (time interval) 18F-FCH (20min) 18F-FDG (20min) 18F-FDG (3h) 
n (mice) 5 5 3 
n (total plaques analyzed en face) 89 73 58 
Correlation r (Spearman) 0.842 0.261 0.476 
P value (Spearman) <0.0001 <0.05 <0.001 
False negative autoradiography (%) 19 51 76 
Sensitivity of tracer for plaque imaging (%) 84 64 57 
Signal-to-noise (plaque-to-nonlesion) 4.9±2.0 to 1 6.0±5.1 to 1 2.6±0.9 to 1 
 
Comparisons of single autoradiographic signals and fat stainings in longitudinally opened atherosclerotic 
aortae; mean±SD. 
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